Trial Details

Not Recruiting
Basic Information
Clinical ID c2805
Identifier EUCTR2017-002452-87-GB
Trial Title A randomized, double-blinded, comparative trial comparing the incidence of hypophosphatemia in relation to repeated treatment courses of iron isomaltoside and ferric carboxymaltose in subjects with iron deficiency anaemia due to inflammatory bowel disease - hypophosphatemia following IV iron therapy in IDA due to IBD
Trial URL Visit Original Page
Study Information
Study Results

No results available
Conditions Iron deficiency anaemia due to inflammatory bowel disease MedDRA version: 20.0_Level: LLT_Classification code 10002062_Term: Anaemia iron deficiency_System Organ Class: 100000004851_;Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
Interventions Trade Name: Monofer 100mg/ml Product Name: Monofer 100mg/ml Pharmaceutical Form: Solution for injection/infusion INN or Proposed INN: Ferric derisomaltose CAS Number: 0994-66-4 Current Sponsor code: Iron oligosaccharide complex Other descriptive name: IRON(III) ISOMALTOSIDE 1000 Concentration unit: IU/mg international unit(s)/milligram Concentration type: up to Concentration number: 2000- Trade Name: Ferinject Product Name: Ferinject Pharmaceutical Form: Solution for injection/infusion INN or Proposed INN: ferric carboxymaltose CAS Number: 9007-72-1 Current Sponsor code: Iron complex ferric carboxymaltose Other descriptive name: Iron trivalent Concentration unit: IU/mg international unit(s)/milligram Concentration type: up to Concentration number: 2000-
Participant Information
Sponsor Pharmacosmos A/S
City -
Country/Region Austria;Denmark;Germany;United Kingdom;Sweden
Enrollment Criteria
Sex Requirement NOT SPECIFIED
Age Requirement -
Study Design
Study Type Interventional clinical trial of medicinal product
Phase PHASE4
Time Information
Start Date 2025-04-24
Primary Completion Date -
Completion Date -